Deals: Tanox To Acquire Antibodies From Sunol Molecular Corp. For Potential Treatment Of Inflammatory Disease, Cancer

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Deals review
Deal details

Tanox to Acquire Antibodies from Sunol Molecular Corp. for Potential Treatment of Inflammatory Disease, Cancer

In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits PL Intelligence has to offer. Find out more.

Request a demo of
PL Intelligence

Dyax Corp. Grants Use of its Antibody Phage Display Libraries to Tanox, Inc. for Therapeutic Antibody Development

Capricorn pharmaceuticals acquires therapeutic antibody clinical program and antibody technologies from Sunol Molecular

Protein Design Labs and Tanox announce antibody patents agreement

Nycomed and Micromet Enter Into Exclusive Worldwide Collaboration to Develop and Commercialize anti-GM-CSF Antibodies for the Treatment of Inflammatory and Autoimmune Diseases

Unigene In-Licenses Potential Therapies for Inflammation and Cardiovascular Disease from University of London

Genentech, Novartis and Tanox Settle Disputes Surrounding Xolair and TNX-901

Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen

GlycoDesign to collaborate with The Brigham and Women's Hospital

Tanox to Expand Manufacturing Capacity With Facility in San Diego

Related categories

Therapeutic target

Industry sector

More deals

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us

Tanox to Acquire Antibodies from Sunol Molecular Corp. for Potential Treatment of Inflammatory Disease, Cancer

Related deals

Related categories

More deals

Latest deals

Most viewed deals

By month